greeksoup/ stocks
Stocks / Foreign companies / AZN · Pharmaceutical Preparations

AstraZeneca PLC (AZN)

AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2025 it reported revenue of USD 58,739 million, up 8.6% on the year before. Its profit attributable to shareholders was USD 10,225 million, up 45.3%, and diluted earnings per share USD 6.54.

Earnings per share are per ordinary share, in US dollars. The share that trades in the US can be a depositary share standing for more or fewer ordinary shares, so no price ratio is worked out on this page.

The public record on AZN

Planned insider sales1 Form 144 notice in twelve months, $1.3 million; latest 12 November 2025
Options tapeput/call 0.41 by open interest on 26 September 2026; the straddle prices a 5.1% move to 16 October 2026
Holders8 of the followed funds hold it; largest Norges Bank; 1 Schedule 13D or 13G filing in twelve months
Congress0 House trades disclosed in six months
Short interest2.1 million shares short, 1.00 days to cover at 15 September 2026

Profit and loss, 11 fiscal years

Year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Revenue58,73954,07345,81144,35137,41726,61724,38422,09022,46523,00224,708
Cost of sales10,63310,2078,26812,39112,4375,2994,9214,9364,3184,1264,646
Gross profit48,10643,86637,54331,96024,98021,31819,46317,15418,14718,87620,062
Research and development14,23213,58310,9359,7629,7365,9916,0595,9325,7575,8905,997
Selling, general and administrative19,93319,97719,21618,41915,23411,29411,68210,03110,2339,41311,112
Operating profit13,74310,0038,1933,7571,0565,1622,9243,3873,6774,9024,114
Finance costs1,6941,7421,6261,3461,3001,3061,4321,4191,5081,3841,075
Profit before tax12,4028,6916,8992,501-2653,9161,5481,9932,2273,5523,069
Income tax2,1691,650938-792-380772321-57.0-641146243
Profit for the year10,2337,0415,9613,2931153,1441,2272,0502,8683,4062,826
Profit attributable to shareholders10,2257,0355,9553,2881123,1961,3352,1553,0013,4992,825

USD million, from each year's annual report on the SEC's EDGAR, the year linked to its filing, on the IFRS tags the company filed. A line the company does not file under the standard tag is left out rather than estimated. Profit for the year includes the part that belongs to minority shareholders; profit attributable to shareholders is the part EPS is struck on.

Year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Diluted EPS6.544.503.812.110.082.441.031.702.372.762.23
Basic EPS6.604.543.842.120.082.441.031.702.372.772.23

USD per ordinary share, as filed.

Cash flow

Year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Cash from operations14,57511,86110,3459,8085,9634,7992,9692,6183,5784,1453,324
Purchase of property, plant and equipment2,8101,9241,3611,0911,0919619791,0431,3261,4461,328
Free cash flow11,7659,9378,9848,7174,8723,8381,9901,5752,2522,6991,996
Dividends paid4,9714,6294,4814,3643,8563,5723,5923,4843,5193,5613,486

USD million. Purchase of property, plant and equipment is the cash line as filed; purchases of intangible assets and acquisitions are not in it. Free cash flow is cash from operations less that purchase, arithmetic on the two filed lines.

Balance sheet at year end

Year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Total assets114,074104,035101,11996,483105,36366,72961,37760,65163,35462,52660,056
Equity attributable to shareholders48,66740,78639,14337,03739,26815,62213,12712,46814,96014,85418,490
Cash and cash equivalents5,7115,4885,8406,1666,3297,8325,3694,8313,3245,0186,240
Borrowings, as filed29,62230,29528,62229,23230,78120,38018,22719,11317,807n/an/a
Lease liabilities1,8031,4521,128953987681675n/an/an/an/a
Trade and other receivables15,17712,97212,12610,5219,6447,0225,7615,5745,0094,5736,622
Inventories6,5575,2885,4244,6998,9834,0243,1932,8903,0352,3342,143
Goodwill21,24221,02520,04819,82019,99711,84511,66811,70711,82511,65811,800

USD million, at each fiscal year end. Borrowings is the company's own stated total where it files one; it is never added up from its parts here.

Ratios on the filed lines

Year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Gross margin81.9%81.1%82.0%72.1%66.8%80.1%79.8%77.7%80.8%82.1%81.2%
Operating margin23.4%18.5%17.9%8.5%2.8%19.4%12.0%15.3%16.4%21.3%16.7%
Net margin17.4%13.0%13.0%7.4%0.3%12.0%5.5%9.8%13.4%15.2%11.4%
Free cash flow margin20.0%18.4%19.6%19.7%13.0%14.4%8.2%7.1%10.0%11.7%8.1%
Return on year-end equity21.0%17.2%15.2%8.9%0.3%20.5%10.2%17.3%20.1%23.6%15.3%
Effective tax rate17.5%19.0%13.6%-31.7%n/a19.7%20.7%-2.9%-28.8%4.1%7.9%

Arithmetic on the filed lines of the same year: margins over revenue, return on equity as profit attributable to shareholders over year-end equity, tax over profit before tax.

Annual reports on EDGAR

FormYear toFiled
20-F31 December 202524 February 2026EDGAR
20-F31 December 202418 February 2025EDGAR
20-F31 December 202320 February 2024EDGAR
20-F31 December 202221 February 2023EDGAR
20-F31 December 202122 February 2022EDGAR
20-F31 December 202016 February 2021EDGAR
20-F31 December 20193 March 2020EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install